MiR-206 integrates multiple components of differentiation pathways to control the transition from growth to differentiation in rhabdomyosarcoma cells

Skeletal Muscle

Volumn 2, Issue 1, 2012, Pages

  MacQuarrie, Kyle L ^a,b   Yao, Zizhen ^a   Young, Janet M ^a   Cao, Yi ^a   Tapscott, Stephen J ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

MiR 206; MSC; Myogenesis; Rhabdomyosarcoma; RUNX1; ZNF238

Indexed keywords

EID: 84864912915     PISSN: None     EISSN: 20445040     Source Type: Journal    
DOI: 10.1186/2044-5040-2-7     Document Type: Article

References (38)

1. Xia SJ, Pressey JG, Barr FG. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol Ther 2002, 1:97-104.
2. Merlino G, Khanna C. Fishing for the origins of cancer. Genes Dev 2007, 21:1275-1279. 10.1101/gad.1563707, 17545462.
3. Sebire NJ, Malone M. Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas. J Clin Pathol 2003, 56:412-416. 10.1136/jcp.56.6.412, 1769965, 12783965.
4. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987, 51:987-1000. 10.1016/0092-8674(87)90585-X, 3690668.
5. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA 1989, 86:5434-5438. 10.1073/pnas.86.14.5434, 297637, 2748593.
6. Weintraub H, Davis R, Tapscott S, Thayer M, Krause M, Benezra R, Blackwell TK, Turner D, Rupp R, Hollenberg S, Zhang Y, Lassar A. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991, 251:761-766. 10.1126/science.1846704, 1846704.
7. Tapscott SJ, Thayer MJ, Weintraub H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 1993, 259:1450-1453. 10.1126/science.8383879, 8383879.
8. Yang Z, MacQuarrie KL, Analau E, Tyler AE, Dilworth FJ, Cao Y, Diede SJ, Tapscott SJ. MyoD and E-protein heterodimers switch rhabdomyosarcoma cells from an arrested myoblast phase to a differentiated state. Genes Dev 2009, 23:694-707. 10.1101/gad.1765109, 2661613, 19299559.
9. Lassar AB, Davis RL, Wright WE, Kadesch T, Murre C, Voronova A, Baltimore D, Weintraub H. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991, 66:305-315. 10.1016/0092-8674(91)90620-E, 1649701.
10. Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJLF, Winokur ST, Tawil R, van der Maarel SM, Filippova GN, Tapscott SJ. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 2009, 18:2414-2430. 10.1093/hmg/ddp180, 2694690, 19359275.
11. Cao Y, Yao Z, Sarkar D, Lawrence M, Sanchez GJ, Parker MH, MacQuarrie KL, Davison J, Morgan MT, Ruzzo WL, Gentleman RC, Tapscott SJ. Genome-wide MyoD binding in skeletal muscle cells: a potential for broad cellular reprogramming. Dev Cell 2010, 18:662-674. 10.1016/j.devcel.2010.02.014, 2910615, 20412780.
12. Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988, 242:405-411. 10.1126/science.3175662, 3175662.
13. Davis RL, Cheng PF, Lassar AB, Weintraub H. The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell 1990, 60:733-746. 10.1016/0092-8674(90)90088-V, 2155707.
14. Cohen MM. Perspectives on RUNX genes: an update. Am J Med Genet A 2009, 149A:2629-2646. 10.1002/ajmg.a.33021, 19830829.
15. Zhu X, Yeadon JE, Burden SJ. AML1 is expressed in skeletal muscle and is regulated by innervation. Mol Cell Biol 1994, 14:8051-8057. 359343, 7969143.
16. Wang X, Blagden C, Fan J, Nowak SJ, Taniuchi I, Littman DR, Burden SJ. Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle. Genes Dev 2005, 19:1715-1722. 10.1101/gad.1318305, 1176009, 16024660.
17. Penn BH, Bergstrom DA, Dilworth FJ, Bengal E, Tapscott SJ. A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation. Genes Dev 2004, 18:2348-2353. 10.1101/gad.1234304, 522984, 15466486.
18. Yokoyama S, Ito Y, Ueno-Kudoh H, Shimizu H, Uchibe K, Albini S, Mitsuoka K, Miyaki S, Kiso M, Nagai A, Hikata T, Osada T, Fukuda N, Yamashita S, Harada D, Mezzano V, Kasai M, Puri PL, Hayashizaki Y, Okado H, Hashimoto M, Asahara H. A systems approach reveals that the myogenesis genome network is regulated by the transcriptional repressor RP58. Dev Cell 2009, 17:836-848. 10.1016/j.devcel.2009.10.011, 3110151, 20059953.
19. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006, 174:677-687. 10.1083/jcb.200603008, 2064311, 16923828.
20. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T, Ponzetto C. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009, 119:2366-2378. 2719932, 19620785.
21. Wang H, Garzon R, Sun H, Ladner K, Singh R, Dahlman J, Cheng A, Hall B, Qualman S, Chandler D, Croce CM, Guttridge DC. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381. 10.1016/j.ccr.2008.10.006, 18977326.
22. Rao PK, Missiaglia E, Shields L, Hyde G, Yuan B, Shepherd CJ, Shipley J, Lodish HF. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhambomyosarcoma cells. FASEB J 2010, 24:1-11. 10.1096/fj.10-0101ufm, 20047894.
23. Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, Renard M, Sciot R, Rao P, Oberlin O, Delattre O, Shipley J. MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer 2010, 102:1-9. 10.1038/sj.bjc.6605457, 2813738, 19935796.
24. Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang D-Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006, 38:228-233. 10.1038/ng1725, 2538576, 16380711.
25. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 2006, 175:77-85. 10.1083/jcb.200603039, 2064500, 17030984.
26. Cao Y, Kumar RM, Penn BH, Berkes CA, Kooperberg C, Boyer LA, Young RA, Tapscott SJ. Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters. EMBO J 2006, 25:502-511. 10.1038/sj.emboj.7600958, 1383539, 16437161.
27. Sang L, Coller HA, Roberts JM. Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 2008, 321:1095-1100. 10.1126/science.1155998, 2721335, 18719287.
28. Fischer A, Gessler M. Delta-Notch-and then? Protein interactions and proposed modes of repression by Hes and Hey bHLH factors. Nucleic Acids Res 2007, 35:4583-4596. 10.1093/nar/gkm477, 1950541, 17586813.
29. Kopan R, Nye JS, Weintraub H. The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 1994, 120:2385-2396.
30. Lindsell CE, Shawber CJ, Boulter J, Weinmaster G. Jagged: a mammalian ligand that activates Notch1. Cell 1995, 80:909-917. 10.1016/0092-8674(95)90294-5, 7697721.
31. Buas MF, Kabak S, Kadesch T. Inhibition of myogenesis by Notch: evidence for multiple pathways. J Cell Physiol 2009, 218:84-93. 10.1002/jcp.21571, 18727102.
32. Lu J, Webb R, Richardson JA, Olson EN. MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc Natl Acad Sci USA 1999, 96:552-557. 10.1073/pnas.96.2.552, 15174, 9892671.
33. Lassar AB, Buskin JN, Lockshon D, Davis RL, Apone S, Hauschka SD, Weintraub H. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer. Cell 1989, 58:823-831. 10.1016/0092-8674(89)90935-5, 2550138.
34. Weintraub H, Davis R, Lockshon D, Lassar A. MyoD binds cooperatively to two sites in a target enhancer sequence: occupancy of two sites is required for activation. Proc Natl Acad Sci USA 1990, 87:5623-5627. 10.1073/pnas.87.15.5623, 54379, 2377600.
35. Gilmour BP, Fanger GR, Newton C, Evans SM, Gardner PD. Multiple binding sites for myogenic regulatory factors are required for expression of the acetylcholine receptor gamma-subunit gene. J Biol Chem 1991, 266:19871-19874.
36. Piette J, Bessereau JL, Huchet M, Changeux JP. Two adjacent MyoD1-binding sites regulate expression of the acetylcholine receptor alpha-subunit gene. Nature 1990, 345:353-355. 10.1038/345353a0, 2342565.
37. Wentworth BM, Donoghue M, Engert JC, Berglund EB, Rosenthal N. Paired MyoD-binding sites regulate myosin light chain gene expression. Proc Natl Acad Sci USA 1991, 88:1242-1246. 10.1073/pnas.88.4.1242, 50993, 1847512.
38. Song G, Zhang Y, Wang L. MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009, 284:31921-31927. 10.1074/jbc.M109.046862, 2797263, 19723635.